查询: 取消
免责声明:证券数据为本网搜集归纳,尽量保证及时准确,入市投资请以上市公司公布的正式公告为准。本网证券行情存在延时,交易请以交易所即时行情价格为准。所有数据仅供参考,据此入市风险自担。
诺唯赞(688105)研究和试验发展
上涨家数:22下跌家数:7平均涨幅:+1.68%
更新时间:2025-09-30 15:00
名称最新价(元)市盈率(倍)涨跌幅
药明康德112.0324.01+6.42%
皓元医药82.6061.92+6.36%
美迪西69.44-34.11+4.85%
普蕊斯47.9435.85+4.67%
百花医药9.4982.38+4.63%
诺思格55.0037.19+3.77%
中源协和24.72158.60+3.56%
成都先导24.67108.38+3.35%
泰坦科技25.06234.67+2.92%
康龙化成35.7546.02+2.61%
药康生物18.0670.93+2.27%
药石科技41.4250.09+2.17%
百普赛斯59.5666.23+1.79%
泓博医药34.81187.84+1.75%
近岸蛋白43.29-43.56+1.55%
和元生物7.87-16.32+1.42%
毕得医药76.9150.29+1.30%
诺唯赞23.21-296.60+0.74%
万邦医药41.7448.56+0.68%
义翘神州74.3076.16+0.23%
益诺思46.90178.96+0.21%
南模生物50.78117.11+0.04%
博济医药10.00271.300.00%
昭衍新药35.3086.86-0.03%
百诚医药60.00-35.65-0.08%
阿拉丁13.0354.20-0.69%
睿智医药11.41-41.12-0.78%
阳光诺和66.0446.62-1.14%
泰格医药58.00168.92-1.21%
奥浦迈64.22211.60-2.95%

转至诺唯赞(688105)行情首页

中财网版权所有(C) HTTP://WWW.CFi.CN